Navigated to A New FDA Approval Brings New Psychiatric Risks

A New FDA Approval Brings New Psychiatric Risks

September 1
16 mins

View Transcript

Episode Description

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.


CME: Take the CME Post-Test for this Episode

Published On: 09/01/2025

Duration: 16 minutes, 42 seconds


Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.